Anacetrapib: new hope for cholesteryl ester transfer protein inhibitors in the treatment of dyslipidemia.
Vergeer
Menno
M
Department of Vascular Medicine, Academic Medical Center in Amsterdam, The Netherlands.
Kastelein
John J P
JJ